DCMIC
NBSE

Decheng Capital Management III (Cayman)’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Decheng Capital Management III (Cayman)’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$92.5K Hold
2023
Q1 		$185K Hold
2022
Q4 		$190K Hold
2022
Q3 		$395K Hold
2022
Q2 		$1.05M Hold
2022
Q1 		$1.88M Buy